Metoprolol (tartrate)

Metoprolol tartrate is an orally active, selective β1-adrenoceptor antagonist. Metoprolol tartrate shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].

Product Specifications

CAS Number

[56392-17-7]

UNSPSC

12352005

Hazard Statement

H361, H411

Target

Adrenergic Receptor; Apoptosis

Type

Reference compound

Related Pathways

Apoptosis; GPCR/G Protein; Neuronal Signaling

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Cancer; Infection; Endocrinology; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/metoprolol-tartrate.html

Purity

99.98

Solubility

DMSO : 70 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

OC(CNC(C)C)COC1=CC=C(CCOC)C=C1.O=C(O)[C@H](O)[C@@H](O)C(O)=O.[0.5]

Molecular Formula

C15H25NO3.1/2C4H6O6

Molecular Weight

342.41

Precautions

H361, H411

References & Citations

[1]Ulleryd MA, et al. Metoprolol reduces proinflammatory cytokines and atherosclerosis in ApoE-/- mice. Biomed Res Int. 2014;2014:548783.|[2]Wang D, et al. Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis. Gene. 2014 Sep 1;547 (2) :195-201.|[3]Hajatbeigi B, et al. Cytotoxicity of Metoprolol on Leukemic Cells in Vitro. IJBC 2018; 10 (4) : 124-129.|[4]Su Q, et al. Effect of metoprolol on myocardial apoptosis and caspase-9 activation after coronary microembolization in rats. Exp Clin Cardiol. 2013 Spring;18 (2) :161-5.